Bizily Scott — SEC Form 4 filings
SEC reporting owner CIK 1920738. 26 Form 4 filings on record with FilingPulse; latest filed 2026-09-03.
Transaction summary — filings shown
Covers all 26 filings on record, filed 2024-02-12 to 2026-09-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 28 legs across 24 filings — 72,511 shares, $1,515,106 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 76.
- Largest priced transaction: sale of 8,153 shares @ $31.78 ($259,102) in 4D Molecular Therapeutics, Inc., filed 2024-04-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| 4D Molecular Therapeutics, Inc. (FDMT) | Chief Legal Officer | 26 | — | 28 legs · 72,511 sh · $1,515,106 | 76 |
Form 4 filings — Bizily Scott
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-03 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Option exercise (M): 584 @ $6.49 · Sale (S): 584 @ $14 · Option exercise (M): 584 (derivative) @ $0 | EDGAR |
| 2026-08-17 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Option exercise (M): 1,635 @ $4.14 · Sale (S): 1,635 @ $12 · Option exercise (M): 1,635 @ $4.14 · Sale (S): 1,635 @ $12.20 · Option exercise (M): 1,635 (derivative) @ $0 · Option exercise (M): 1,635 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Option exercise (M): 814 @ $4.14 · Option exercise (M): 5,752 @ $6.49 · Sale (S): 6,566 @ $14 · Option exercise (M): 814 (derivative) @ $0 · Option exercise (M): 5,752 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Option exercise (M): 9,810 @ $4.14 · Sale (S): 9,810 @ $12 · Option exercise (M): 9,810 (derivative) @ $0 | EDGAR |
| 2026-03-27 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/award (A): 217,000 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Option exercise (M): 1,635 @ $4.14 · Sale (S): 1,635 @ $10.90 · Option exercise (M): 1,635 (derivative) @ $0 | EDGAR |
| 2025-11-19 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Option exercise (M): 1,635 @ $4.14 · Sale (S): 1,635 @ $10.59 · Option exercise (M): 1,635 (derivative) @ $0 | EDGAR |
| 2025-10-27 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Option exercise (M): 1,084 @ $6.49 · Sale (S): 2,678 @ $12 · Option exercise (M): 1,084 (derivative) @ $0 | EDGAR |
| 2025-10-20 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Option exercise (M): 1,635 @ $4.14 · Sale (S): 1,635 @ $10.17 · Option exercise (M): 1,635 (derivative) @ $0 | EDGAR |
| 2025-10-14 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale (S): 2,408 @ $10 | EDGAR |
| 2025-09-26 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Sale (S): 2,407 @ $8 | EDGAR |
| 2025-03-10 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/award (A): 78,500 (derivative) @ $0 | EDGAR |
| 2024-09-18 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Option exercise (M): 500 @ $6.49 · Sale (S): 500 @ $16.33 · Option exercise (M): 500 (derivative) @ $0 | EDGAR |
| 2024-08-21 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Option exercise (M): 500 @ $6.49 · Sale (S): 500 @ $15 · Option exercise (M): 500 (derivative) @ $0 | EDGAR |
| 2024-07-18 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Option exercise (M): 500 @ $6.49 · Option exercise (M): 1,250 @ $8.04 · Sale (S): 1,750 @ $27.11 · Option exercise (M): 500 (derivative) @ $0 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2024-07-15 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Option exercise (M): 1,996 @ $15.78 · Sale (S): 1,996 @ $25 · Option exercise (M): 1,996 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Option exercise (M): 1,332 @ $6.49 · Option exercise (M): 2,916 @ $8.04 · Sale (S): 4,248 @ $21.36 · Option exercise (M): 1,332 (derivative) @ $0 · Option exercise (M): 2,916 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Option exercise (M): 500 @ $6.49 · Option exercise (M): 1,250 @ $8.04 · Sale (S): 1,750 @ $23.71 · Option exercise (M): 500 (derivative) @ $0 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2024-05-20 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Option exercise (M): 500 @ $6.49 · Option exercise (M): 1,250 @ $8.04 · Sale (S): 1,283 @ $25.34 · Sale (S): 467 @ $25.75 · Option exercise (M): 500 (derivative) @ $0 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2024-04-18 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Option exercise (M): 500 @ $6.49 · Option exercise (M): 1,250 @ $8.04 · Sale (S): 1,750 @ $25.74 · Option exercise (M): 500 (derivative) @ $0 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Option exercise (M): 1,332 @ $6.49 · Option exercise (M): 2,916 @ $8.04 · Option exercise (M): 1,996 @ $15.78 · Option exercise (M): 1,909 @ $20.24 · Sale (S): 8,153 @ $31.78 · Option exercise (M): 1,332 (derivative) @ $0 · +3 more | EDGAR |
| 2024-03-29 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Option exercise (M): 4,342 @ $25.98 · Option exercise (M): 1,491 @ $25.98 · Sale (S): 5,833 @ $35.04 · Option exercise (M): 4,342 (derivative) @ $0 · Option exercise (M): 1,491 (derivative) @ $0 | EDGAR |
| 2024-03-20 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Option exercise (M): 500 @ $6.49 · Option exercise (M): 1,250 @ $8.04 · Sale (S): 1,750 @ $31.27 · Option exercise (M): 500 (derivative) @ $0 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2024-02-29 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Option exercise (M): 1,909 @ $20.24 · Sale (S): 1,909 @ $30 · Option exercise (M): 1,909 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Option exercise (M): 500 @ $6.49 · Option exercise (M): 1,250 @ $8.04 · Sale (S): 1,750 @ $27.67 · Option exercise (M): 500 (derivative) @ $0 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2024-02-12 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Option exercise (M): 1,332 @ $6.49 · Sale (S): 1,332 @ $27.50 · Option exercise (M): 2,916 @ $8.04 · Sale (S): 2,916 @ $27.50 · Option exercise (M): 1,996 @ $15.78 · Sale (S): 1,996 @ $27.50 · +3 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1920738 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →